|
LACTB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.120300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.275910E-02 |
| Normal-vs-Stage2 |
3.058400E-03 |
| Normal-vs-Stage3 |
1.273610E-02 |
| Normal-vs-Stage4 |
8.898200E-03 |
| Stage1-vs-Stage2 |
2.098600E-01 |
| Stage1-vs-Stage3 |
5.517200E-01 |
| Stage1-vs-Stage4 |
1.907810E-01 |
| Stage2-vs-Stage3 |
5.002200E-01 |
| Stage2-vs-Stage4 |
9.553200E-01 |
| Stage3-vs-Stage4 |
4.826000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.302290E-02 |
| Normal-vs-AfricanAmerican |
2.559600E-02 |
| Normal-vs-Asian |
1.236390E-02 |
| Caucasian-vs-AfricanAmerican |
2.021000E-01 |
| Caucasian-vs-Asian |
3.787800E-01 |
| AfricanAmerican-vs-Asian |
6.000600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.905900E-02 |
| Normal-vs-Female |
1.216480E-03 |
| Male-vs-Female |
3.879000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.778300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.877900E-03 |
| Normal-vs-Age(61-80Yrs) |
7.874300E-02 |
| Normal-vs-Age(81-100Yrs) |
8.252400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.961600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.165200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.672800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.059400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.112600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.471800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.045600E-01 |
| Classical-VS-Follicular |
9.56970000000057E-05 |
| Classical-VS-Other |
4.935400E-01 |
| Classical-VS-Normal |
2.791800E-02 |
| Tall-VS-Follicular |
1.294440E-02 |
| Tall-VS-Other |
5.066200E-01 |
| Tall-VS-Normal |
3.439200E-01 |
| Follicular-VS-Other |
5.225800E-01 |
| Follicular-VS-Normal |
1.46300000003485E-06 |
| Other-VS-Normal |
8.683700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.950400E-04 |
| Normal-vs-N1 |
7.276000E-03 |
| N0-vs-N1 |
8.324000E-01 |
|
|
